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SUMMARY
Objective: Oligohydramnios is associated with increased perinatal morbidity and mortality. It may be due to
a variety of conditions, including rupture of membranes, fetal urinary tract abnormalities such as megacystis
caused by posterior urethral valve, and prerenal abnormalities involving uteroplacental insufficiency possibly
due to hypertension, and hyperthyroidism. Hyperthyroidism affects 0.2% of pregnant women and is associated
with a higher risk of pre-eclampsia. We report a case that presented initially with early-onset oligohydramnios
and later developed a hypertensive crisis that was associated with undiagnosed hyperthyroidism. A
pheochromocytoma was also suspected because of increased 24-hour urine vanillylmandelic acid excretion
but was dismissed after imaging studies.
Case Report: A 36-year-old woman, gravida 2, para 1, was referred to our hospital because of a high-risk
result on maternal serum Down syndrome screening (risk, 1:40) at a gestational age of 22 weeks. A hypertensive
crisis developed and her condition deteriorated rapidly, so the pregnancy was terminated. Subsequent
investigation revealed previously undiagnosed hyperthyroidism and increased urine 24-hour vanillylmandelic
acid excretion. Magnetic resonance imaging failed to reveal any signs of a pheochromocytoma or an ectopic
adrenal gland. Hypertension and hyperthyroidism were controlled medically 6 weeks postpartum. Urine
catecholamine levels returned to normal 3 days postpartum.
Conclusions: A combination of hypertension, oligohydramnios and hyperthyroidism is rare. An elevated 24-
hour urine vanillylmandelic acid of unknown origin is a previously unreported finding, to the best of our
knowledge, associated with hyperthyroidism and pregnancy-induced hypertension. [Taiwanese J Obstet Gynecol
2004;43(4):222–225]
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Introduction
Early-onset oligohydramnios is uncommon and indicates
a poor fetal prognosis. Apart from preterm premature
rupture of membranes, the most common etiology is
fetal anuria caused by either obstructive uropathy or
renal agenesis [1]. Other etiologies include maternal
diseases such as pre-eclampsia, hypertension, diabetes
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and hyperthyroidism. Hyperthyroidism affects 0.2%
of all pregnancies [2]. Of these, the most frequently
encountered pathology is Graves’ disease (~95%) [3].
This usually remits in the second and third trimesters,
and is usually treated medically with propylthiouracil
(PTU) during pregnancy. Pheochromocytoma during
pregnancy is extremely rare, with an estimated prevalence
in full-term pregnancies of 1 in 50,000–54,000 [4].
Magnetic resonance imaging (MRI) can be used to
localize the tumor. Increased urinary excretion of cate-
cholamines and their metabolites is used to diagnose
the condition. An _-adrenergic antagonist is essential
when diagnosis is established. Abdominal delivery is
recommended in patients with pheochromocytoma as
vaginal delivery may worsen the prognosis by stimulating
the synthesis of catecholamines. We report a patient
with early-onset oligohydramnios that might have
been caused by pregnancy-induced hypertension and
untreated hyperthyroidism. The hypertensive crisis in
this patient was accompanied by increased urinary
vanillylmandelic acid excretion without a detectable
pheochromocytoma. Difficulties in diagnosis and man-
agement of such a complicated condition are also dis-
cussed.
Case Report
This 36-year-old, gravida 2, para 1, Taiwanese woman
was referred to our hospital because of high risk on
maternal serum Down syndrome screening (1:40) at a
gestational age of 22 weeks. Her previous pregnancy
had macrosomia (birth weight 4,124 g) and the infant
was delivered by cesarean section. Blood pressure was
normal in this pregnancy prior to her coming to our
hospital, except once when it was elevated to 149/96
mmHg at a gestational age of 10 weeks. No essential
hypertension was noted by the patient. However, blood
pressure peaked at 192/92 mmHg during her first visit
to our hospital and ultrasound examination revealed
severe oligohydramnios (amniotic fluid index, 4.2)
without growth restriction or rupture of membranes
(Figure 1) and she was, thus, admitted.
Shortly after admission, her condition deteriorated
abruptly, with headache, fever (> 39$C), profuse sweat-
ing, hot flushes, confusion, tachycardia (150 beats/min),
tachypnea (28/min) and exacerbation of blood pressure
up to 200/110 mmHg despite repeated intravenous bo-
luses of hydralazine. Laboratory investigations revealed
only thrombocytopenia (platelet count, 99,000/+L)
with normal hepatic and renal function. Electrolytes
and the blood coagulation profile were also normal. No
proteinuria was noted. With severe pregnancy-induced
hypertension the most probable diagnosis, treatment
was initiated with intravenous magnesium sulfate, hydra-
lazine and, later, with intravenous nitroprusside infusion.
Termination of the pregnancy by cesarean section
was offered due to her unfavorable cervical condition
and unstable vital signs. Delivery was uneventful under
general anesthesia. The female fetus weighed 402 g and
had an Apgar score of 1 in the first minute; she died of
respiratory distress shortly after birth.
After delivery, tachycardia persisted but blood pres-
sure decreased to 140/80 mmHg. Immediate post-
partum investigation revealed serum concentrations of
triiodothyronine of 5.1 ng/mL (normal, 0.8–2.0 ng/mL),
free thyroxine of 6.9 +g/dL (normal, 0.6–1.75 +g/dL)
and thyroid-stimulating hormone (TSH) of less than
0.004 +IU/dL, and 24-hour urine vanillylmandelic acid
of 16.5 mg (normal, 1–11 mg). Hydralazine 30 mg/day
and labetalol 200 mg/day were used postpartum (la-
betalol after blood was sampled for laboratory investi-
gations). Propranolol 40 mg/day was given to alleviate
tachycardia. Magnesium sulfate 2 g/day was given dur-
ing the first 24 hours postpartum. PTU 300 mg/day
was administered to control hyperthyroidism. The hy-
perthyroidism was found to be Graves’ disease (from
elevation of TSH receptor antibody), and the patient
received treatment at appropriate subspecialty clinics.
The 24-hour urine vanillylmandelic acid levels returned
from high to normal by 3 days postpartum (15.4 mg on
postpartum day 2 and 7.3 mg on postpartum day 3).
Six weeks postpartum, the patient remained well
and euthyroid, except that residual mild hypertension
(140/100 mmHg) still bothered her occasionally under
medication. Food or drugs that can affect urine cate-
cholamine excretion including coffee, tea, bananas,
chocolate, citrus fruits, vanilla, caffeine, levodopa, lithi-
um, aminophylline, chloral hydrate, clonidine, disul-
Figure 1. Antenatal ultrasound at a gestational age of 22 weeks
shows severe oligohydramnios and a fetus with an appropriate
weight for gestational age.
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firam, erythromycin, insulin, methenamine, methyldopa,
nicotinic acid, quinidine, tetracyclines and nitroglycerin
were carefully sought and excluded.
She did not exercise vigorously before admission,
so hyperthyroidism with a possible pheochromocyto-
ma was suspected. The patient was hesitant about
undergoing MRI initially but this was arranged for 2
weeks postpartum. Unfortunately, it failed to depict
the location of a pheochromocytoma (Figure 2) or an
ectopic adrenal gland. The only finding was an artifact
mass between the liver and the spine (Figure 3). Fetal
cord blood revealed a normal female karyotype (46,
XX). Pathology of the placenta and autopsy of the fetus
both revealed no obvious structural or histologic ab-
normalities. The origin of the increased urine vanillyl-
mandelic acid excretion remains unknown.
Discussion
Hyperthyroidism in pregnancy and its relationship to
oligohydramnios
Pregnancy has a profound effect on thyroid function:
increased hepatic synthesis of thyroid-binding globulins,
a reduced degradation rate due to oligosaccharide
modification, marked elevation of human gonadotro-
pin, increased plasma volume and enlargement of the
gravid thyroid are thought to contribute to the physio-
logic changes in thyroid function during pregnancy
[5]. Hyperthyroidism with oligohydramnios is a rare
condition [6]. Our patient was unusual in two aspects.
First, oligohydramnios was not noted during the preg-
nancy until a gestational age of 22 weeks, and its oc-
currence seemed to be abrupt. Moreover, pathologic
and histologic examination of the placenta did not re-
veal any vascular changes related to long-term hyper-
tension. Autopsy of the fetus also showed no renal ab-
normalities. The commonest cause of hyperthyroidism
in pregnancy is Graves’ disease (85–95%), but other
causes include toxic multinodular goiter, toxic adenoma,
subacute thyroiditis, hyperemesis gravidarum, hydatidi-
form mole and struma ovarii. Congestive heart failure
and thyroid storm may also occur and the risk of pre-
eclampsia is significantly higher. A 5.6% incidence of
fetal death or stillbirth together with a further 5%
incidence of fetal or neonatal abnormalities has been
noted. Hyperthyroidism should therefore be controlled
during pregnancy [7].
Hypertension and the origin of increased urinary
excretion of vanillylmandelic acid
Pheochromocytoma is a catecholamine-secreting tumor
derived from chromaffin tissue. Signs of pheochromo-
cytoma include paroxysmal or sustained hyperten-
sion, headache, sweating, palpitations, nausea, tremor
and anxiety. It is difficult to distinguish between pre-
eclampsia and pheochromocytoma during pregnancy.
One important distinction is that patients with pheo-
chromocytoma usually do not have proteinuria, which
is a prominent feature of pre-eclampsia [4]. The 24-
hour urinary excretion of catecholamines and their
metabolites is used for biochemical diagnosis. Vanil-
lylmandelic acid is the least sensitive marker compared
to epinephrine, norepinephrine, metanephrine and dopa-
mine in diagnosing pheochromocytoma, but it is the
most specific. Hence, the elevated 24-hour urinary vanil-
lylmandelic acid could not be neglected in our patient.
Clues of pheochromocytoma in our patient included
the lack of proteinuria with aggravating hypertension,
palpitations, tachycardia and headache. These clues
Figure 2. T1-weighted magnetic resonance image showing no
adrenal tumor.
Figure 3. T1-weighted magnetic resonance image showing a
bright mass between the liver and the spine, which corresponds
to the location of the sympathetic ganglions and was initially
regarded as an ectopic adrenal gland, but later was proved to
be an artifact by transverse magnetic resonance imaging scan
and ultrasound.
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can only be partially explained by a thyroid storm, and
pheochromocytoma was included in the differential
diagnosis because of the hypertensive crisis.
MRI is the preferred imaging study during pregnancy.
Pheochromocytoma usually appears as a bright mass
on a T2-weighted image, which allows a radiologist to
distinguish pheochromocytoma from asymptomatic or
incidental adrenal adenoma found in 5% of the normal
population [8].
Urinary catecholamines have been reported to be
modestly elevated during pre-eclampsia and eclampsia
and after labetalol infusion [4,9]. However, no pre-
eclampsia or eclampsia was noted in our patient. In
addition, a thyroid storm flaring during the second
trimester is an unusual presentation. The literature
shows that TSH antibody activity usually declines during
the second trimester [10]. Release of stress hormones
during the hypertensive crisis and hyperthyroidism ap-
peared to be the etiology of the increased excretion of
urinary vanillylmandelic acid in our patient.
Was our patient only unfortunate to have this rare
combination or was she a victim of another syndrome?
Multiple endocrine neoplasia IIA (MENIIA), or Sipple’s
syndrome, is a well-characterized disorder caused by a
mutation in the RET proto-oncogene located on chro-
mosome 10. The disorder includes medullary thyroid
carcinoma, parathyroid hyperplasia and pheochromo-
cytoma [11]. However, our patient does not fit the
criteria for this syndrome because her electrolytes were
normal and no pheochromocytoma was detected on
imaging studies.
What have we learned from this patient?
Our case demonstrates an atypical presentation of
hyperthyroidism in pregnancy with marked hypertension.
Heat intolerance, weight loss, tremor and tachycardia
should raise the suspicion of hyperthyroidism. Antenatal
recognition of pheochromocytoma is vital because of
the improved maternal and fetal outcome, and it is also
helpful so that an appropriate mode of delivery can be
chosen. Graves’ disease, although it usually lessens in
the second trimester [5], can still cause a thyroid-storm-
like picture in the second trimester, as described here.
Despite the fact that the origin of the vanillylmandelic
acid remains unknown, abrupt-onset hypertension
without proteinuria should alert the clinician to the
possibility of pheochromocytoma. We demonstrate
here that the coexistence of two or more rare diseases
is possible, especially when the clinical presentation is
atypical, that is, if they cannot be explained by a single
etiology. The elevated 24-hour urinary excretion of
vanillylmandelic acid without a pheochromocytoma is,
to the best of our knowledge, a previously unreported
finding.
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